Hematology

Hodgkin Lymphoma   

Questions discussed in this category



Given nationwide shortage in vinblastine, several of my patients under active therapy are facing delays in their therapies. Is it appropriate to subst...

Would you still proceed to high-dose therapy and autologous SCT? Would you incorporate radiation pre- or post- transplant? Or offer additional salvag...

Would the site of disease relapse play a role in your decision (i.e. isolated lymph node recurrence versus failure at primary site of disease)?


Papers discussed in this category


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-05-10

Int. J. Radiat. Oncol. Biol. Phys., 2012 Jun 05

Lancet Haematol, 2020 Oct 01